Table 4 Population descriptive of the Rotterdam Study.
From: CDH6 and HAGH protein levels in plasma associate with Alzheimer’s disease in APOE ε4 carriers
N | Total participants | Incident AD cases | Controls |
|---|---|---|---|
316 | 161 | 155 | |
Age (SD) blood collection, years | 77.16 (5.39) | 77.43 (5.21) | 76.89 (5.59) |
Age at onset/last follow-up (SD) | 84.99 (5.33) | 84.37 (5.01) | 85.63 (5.56) |
Female (%) | 201 (63%) | 104 (65%) | 97 (63%) |
Body Mass index (SD) | 27.32 (4.10) | 27.29 (3.75) | 27.37 (4.46) |
Follow-up (SD) years | 7.82 (2.71) | 6.94 (1.71) | 8.74 (3.22) |
APOE genotype | |||
APOE 44/34/24 | 98 | 68 | 30 |
APOE 33 | 171 | 76 | 95 |
APOE 22/23 | 34 | 13 | 21 |
